Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heidi Altmann

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Scientific Reports|January 30, 2026
¹H-NMR serum metabolomic profiling from clinical routine identifies signatures of progressive melanoma metastasisFrank Friedrich Gellrich, Cosima Hufnagel, Alexander M Funk, et al.
Virchows Archiv : an International Journal of Pathology|June 2, 2026
Tissue biobanking: minimum interface requirements for efficient and high-quality support for biomedical research - a white paperCäcilia Engels, Angela Langer, Britta Fritzsche, et al.
Cancers|October 13, 2021
Targeting Acute Myeloid Leukemia Using the RevCAR Platform: A Programmable, Switchable and Combinatorial StrategyEnrico Kittel-Boselli, Karla Elizabeth González Soto, Liliana Rodrigues Loureiro, et al.
Biopreservation and Biobanking|October 17, 2022
Next Generation Biobanking: Employing a Robotic System for Automated Mononuclear Cell IsolationYannick F Fuchs, Jonathan Brunner, Marc Weigelt, et al.
Scientific Reports|July 8, 2026
Correction: <sup>1</sup>H-NMR serum metabolomic profiling from clinical routine identifies signatures of progressive melanoma metastasisFrank Friedrich Gellrich, Cosima Hufnagel, Alexander M Funk, et al.
Frontiers in Immunology|June 25, 2025
Protective effects for HLA-B*40:01 and C*03:04 in NPM1-mutated AML: result of a large HLA association studyElke Rücker-Braun, Bose Falk, Henning Baldauf, et al.
The Journal of Clinical Endocrinology and Metabolism|September 7, 2022
Circulating Dickkopf1 Parallels Metabolic Adaptations and Predicts Disease Trajectories in Patients With COVID-19Nikolai P Jaschke, Alexander M Funk, Sophie Jonas, et al.
The Journal of Clinical Investigation|September 13, 2022
Immune dysfunction signatures predict outcomes and define checkpoint blockade-unresponsive microenvironments in acute myeloid leukemiaSergio Rutella, Jayakumar Vadakekolathu, Francesco Mazziotta, et al.
Nature Cancer|October 2, 2023
Ex vivo drug response profiling for response and outcome prediction in hematologic malignancies: the prospective non-interventional SMARTrialNora Liebers, Peter-Martin Bruch, Tobias Terzer, et al.
Blood|May 13, 2025
Large B-cell lymphoma imprints a dysfunctional immune phenotype that persists years after treatmentRichard Pelzl, Giulia Benintende, Franziska Gsottberger, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Scientific Reports|January 30, 2026
¹H-NMR serum metabolomic profiling from clinical routine identifies signatures of progressive melanoma metastasisFrank Friedrich Gellrich, Cosima Hufnagel, Alexander M Funk, et al.
Virchows Archiv : an International Journal of Pathology|June 2, 2026
Tissue biobanking: minimum interface requirements for efficient and high-quality support for biomedical research - a white paperCäcilia Engels, Angela Langer, Britta Fritzsche, et al.
Cancers|October 13, 2021
Targeting Acute Myeloid Leukemia Using the RevCAR Platform: A Programmable, Switchable and Combinatorial StrategyEnrico Kittel-Boselli, Karla Elizabeth González Soto, Liliana Rodrigues Loureiro, et al.
Biopreservation and Biobanking|October 17, 2022
Next Generation Biobanking: Employing a Robotic System for Automated Mononuclear Cell IsolationYannick F Fuchs, Jonathan Brunner, Marc Weigelt, et al.
Scientific Reports|July 8, 2026
Correction: <sup>1</sup>H-NMR serum metabolomic profiling from clinical routine identifies signatures of progressive melanoma metastasisFrank Friedrich Gellrich, Cosima Hufnagel, Alexander M Funk, et al.
Frontiers in Immunology|June 25, 2025
Protective effects for HLA-B*40:01 and C*03:04 in NPM1-mutated AML: result of a large HLA association studyElke Rücker-Braun, Bose Falk, Henning Baldauf, et al.
The Journal of Clinical Endocrinology and Metabolism|September 7, 2022
Circulating Dickkopf1 Parallels Metabolic Adaptations and Predicts Disease Trajectories in Patients With COVID-19Nikolai P Jaschke, Alexander M Funk, Sophie Jonas, et al.
The Journal of Clinical Investigation|September 13, 2022
Immune dysfunction signatures predict outcomes and define checkpoint blockade-unresponsive microenvironments in acute myeloid leukemiaSergio Rutella, Jayakumar Vadakekolathu, Francesco Mazziotta, et al.
Nature Cancer|October 2, 2023
Ex vivo drug response profiling for response and outcome prediction in hematologic malignancies: the prospective non-interventional SMARTrialNora Liebers, Peter-Martin Bruch, Tobias Terzer, et al.
Blood|May 13, 2025
Large B-cell lymphoma imprints a dysfunctional immune phenotype that persists years after treatmentRichard Pelzl, Giulia Benintende, Franziska Gsottberger, et al.
Pageof 4